Similar articles

• [Endothelin and kidney disease].

  Nakayama Y, Tomita K. Nakayama Y, et al. Nihon Rinsho. 2004 Sep;62 Suppl 9:655-60. Nihon Rinsho. 2004. PMID: 15506468 Review. Japanese. No abstract available.
• [Physiological and pathophysiological roles of the endothelin converting enzymes].

  Emoto N. Emoto N. Nihon Rinsho. 2004 Sep;62 Suppl 9:636-9. Nihon Rinsho. 2004. PMID: 15506464 Review. Japanese. No abstract available.
• Endothelin receptor antagonists: actions and rationale for their development.

  Warner TD, Battistini B, Doherty AM, Corder R. Warner TD, et al. Biochem Pharmacol. 1994 Aug 17;48(4):625-35. doi: 10.1016/0006-2952(94)90038-8. Biochem Pharmacol. 1994. PMID: 8080434 Review. No abstract available.
• [Involvement of endothelin in the pathogenesis of hypertension and hypertensive target-organ damage].

  Kanno K, Hirata Y. Kanno K, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:164-8. Nihon Rinsho. 2004. PMID: 15171363 Review. Japanese. No abstract available.
• Role of endothelin-1 in myocardial failure.

  Sam F, Colucci WS. Sam F, et al. Proc Assoc Am Physicians. 1999 Sep-Oct;111(5):417-22. doi: 10.1111/paa.1999.111.5.417. Proc Assoc Am Physicians. 1999. PMID: 10519162 Review.